AtriCure Inc (NAS:ATRC)
$ 22.8 -0.965 (-4.06%) Market Cap: 1.10 Bil Enterprise Value: 1.12 Bil PE Ratio: 0 PB Ratio: 2.42 GF Score: 72/100

AtriCure Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 12:30PM GMT
Release Date Price: $59.52 (+4.57%)
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Good morning, everyone. My name is Robbie Marcus. I'm the medical device analyst at JPMorgan, and I'm very happy to kick off the 2021 Virtual JPMorgan conference.

It's an honor to have for our first session today, AtriCure. We got CEO, Mike Carrel. A couple of logistics. It's a little different than having you all live in San Francisco at the Westin. But I'm going to encourage everyone, if you go to the conference web book to submit a question for the Q&A session. Feel free to also e-mail me or Bloomberg chat me. And hopefully, we can try and make it as participatory as possible.

So with that, I'm going to turn it over to Mike and I'll join you for Q&A after. Mike?

Michael H. Carrel
AtriCure, Inc. - CEO, President & Director

Great. Robbie, thank you, and thank you to JPMorgan for allowing us to kick off today. We're honored to be one of the first or if not the first company to kick off the conference this year in this unusual setting on the virtual that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot